trial · primary record
Placebo
Idiopathic Inflammatory Myopathies
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 270 |
| Primary completion | 2030-04-04 |
| Primary endpoint | Total improvement score (TIS) score (continuous) at Week 52 |
| Registry ID | NCT07789015 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:03.676Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07789015
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound